Kuwatsuka, Y., Minami, M., Minami, Y., Sugimoto, K., Hayakawa, F., Miyata, Y., . . . Naoe, T. (2011). The mTOR inhibitor, everolimus (RAD001), overcomes resistance to imatinib in quiescent Ph-positive acute lymphoblastic leukemia cells. Nature Publishing Group.
Stile di citazione ChicagoKuwatsuka, Y., et al. The MTOR Inhibitor, Everolimus (RAD001), Overcomes Resistance to Imatinib in Quiescent Ph-positive Acute Lymphoblastic Leukemia Cells. Nature Publishing Group, 2011.
Citazione MLAKuwatsuka, Y., et al. The MTOR Inhibitor, Everolimus (RAD001), Overcomes Resistance to Imatinib in Quiescent Ph-positive Acute Lymphoblastic Leukemia Cells. Nature Publishing Group, 2011.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.